Parametrica Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parametrica Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,200	Closed	-$683K	–	35
2023 Q2	$683K	Buy	+8,200	New	+$686K	1.31%	21
2022 Q4	–	Sell	-23,500	Closed	-$1.86M	–	80
2022 Q3	$1.86M	Sell	23,500 -12,300	-34%	-$1.04M	3.81%	8
2022 Q2	$2.66M	Sell	35,800 -4,600	-11%	-$345K	2.89%	6
2022 Q1	$3.63M	Buy	+40,400	New	+$3.73M	2.69%	6

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Parametrica Management's XBI Position: Q3 2023 in Review

Parametrica Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 8,200 shares — an estimated $683K sold.

Parametrica Management first reported a position in XBI in Q1 2022 and held it in 4 quarters. The position peaked at $3.63M in Q1 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Parametrica Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Parametrica Management sold 8,200 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $683K.
Parametrica Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 4 quarters.
Parametrica Management's State Street SPDR S&P Biotech ETF position peaked at $3.63M in Q1 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Parametrica Management's 13F filing for Q3 2023, filed 31 Oct 2023.